Bain Capital Public Equity LP Boosts Stock Position in Synopsys, Inc. (NASDAQ:SNPS)

Bain Capital Public Equity LP increased its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 11.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 6,305 shares of the semiconductor company’s stock after buying an additional 670 shares during the quarter. Synopsys comprises 2.0% of Bain Capital Public Equity LP’s holdings, making the stock its 22nd largest position. Bain Capital Public Equity LP’s holdings in Synopsys were worth $3,060,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in SNPS. Vanguard Group Inc. boosted its position in shares of Synopsys by 0.8% during the 4th quarter. Vanguard Group Inc. now owns 14,482,776 shares of the semiconductor company’s stock valued at $7,029,360,000 after acquiring an additional 120,575 shares during the last quarter. Capital World Investors boosted its holdings in Synopsys by 1.6% in the 4th quarter. Capital World Investors now owns 7,280,182 shares of the semiconductor company’s stock valued at $3,533,526,000 after purchasing an additional 114,893 shares during the last quarter. Price T Rowe Associates Inc. MD grew its stake in shares of Synopsys by 21.5% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 5,902,696 shares of the semiconductor company’s stock valued at $2,864,933,000 after buying an additional 1,045,326 shares during the period. Geode Capital Management LLC increased its holdings in shares of Synopsys by 2.3% during the 4th quarter. Geode Capital Management LLC now owns 3,357,165 shares of the semiconductor company’s stock worth $1,625,230,000 after buying an additional 75,298 shares during the last quarter. Finally, Ameriprise Financial Inc. raised its position in shares of Synopsys by 26.2% during the 4th quarter. Ameriprise Financial Inc. now owns 1,888,181 shares of the semiconductor company’s stock valued at $916,441,000 after buying an additional 391,681 shares during the period. Institutional investors and hedge funds own 85.47% of the company’s stock.

Synopsys Stock Up 2.8 %

NASDAQ:SNPS opened at $472.28 on Friday. The company has a market cap of $73.02 billion, a price-to-earnings ratio of 32.53, a price-to-earnings-growth ratio of 3.23 and a beta of 1.23. The company has a fifty day simple moving average of $434.61 and a two-hundred day simple moving average of $489.85. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $624.80.

Insider Buying and Selling at Synopsys

In other news, CEO Sassine Ghazi sold 11,366 shares of the firm’s stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $463.75, for a total transaction of $5,270,982.50. Following the sale, the chief executive officer now owns 70,922 shares of the company’s stock, valued at approximately $32,890,077.50. This trade represents a 13.81 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Geus Aart De sold 15,705 shares of the stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the completion of the transaction, the insider now owns 116,671 shares in the company, valued at $51,850,925.82. This represents a 11.86 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.62% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several research analysts recently weighed in on SNPS shares. Stifel Nicolaus set a $550.00 price objective on Synopsys in a research report on Monday, April 28th. Morgan Stanley lowered their price target on Synopsys from $625.00 to $590.00 and set an “overweight” rating for the company in a report on Monday, February 24th. Rosenblatt Securities restated a “buy” rating and issued a $660.00 price objective on shares of Synopsys in a report on Tuesday, February 25th. KeyCorp lowered their target price on shares of Synopsys from $690.00 to $555.00 and set an “overweight” rating for the company in a research note on Tuesday, April 15th. Finally, Bank of America reduced their price target on shares of Synopsys from $630.00 to $560.00 and set a “buy” rating on the stock in a research note on Wednesday, April 16th. One research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $613.43.

Synopsys Company Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.